Legal Representation
Attorney
Richard J. Greenstone
USPTO Deadlines
Next Deadline
93 days remaining
NOA E-Mailed - SOU Required
Due Date
October 22, 2025
Extension Available
Until April 22, 2026
Application History
19 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Apr 22, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Feb 25, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Feb 25, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Feb 19, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jan 30, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jan 29, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jan 29, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jan 29, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jan 29, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Dec 6, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Dec 5, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Dec 5, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Sep 12, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Sep 12, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Sep 12, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Sep 10, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jun 25, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jun 25, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Feb 20, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 010
Medical device, namely, transcranial magnetic stimulation apparatus, for treating individuals with intellectual and developmental disabilities, namely, Down syndrome, dyslexia, autism spectrum disorder, anxiety, depression, OCD, PTSD, ADHD and Dystonia; medical apparatus, namely, transcranial magnetic stimulation apparatus, for treating attention-deficit/hyperactivity disorder (ADHD), dyslexia, Down syndrome, dyslexia, autism spectrum disorder, anxiety, depression, OCD, PTSD, ADHD, and Dystonia; medical device, namely, transcranial magnetic stimulation apparatus, for treating Turner syndrome, cystic fibrosis, and Trisomy 13
Additional Information
Design Mark
The mark consists of a design of a DNA double helix above the stylized text "GENEX".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
010